Controversies in COX-2 selective inhibition

J Rheumatol. 2002 Jul;29(7):1501-10.
No abstract available

Publication types

  • Comparative Study
  • Consensus Development Conference
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Arthritis, Rheumatoid / diagnosis
  • Arthritis, Rheumatoid / drug therapy*
  • Aspirin / adverse effects*
  • Aspirin / therapeutic use
  • Cyclooxygenase Inhibitors / adverse effects*
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Female
  • Gastrointestinal Diseases / chemically induced*
  • Gastrointestinal Diseases / physiopathology
  • Humans
  • Male
  • Maximum Tolerated Dose
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Sensitivity and Specificity

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase Inhibitors
  • Aspirin